NanOlogy Presents Clinical Research at 2023 DDW and ASCO Involving its Large Surface Area Microparti

FORT WORTH, Texas--(BUSINESS WIRE)--NanOlogy LLC, a clinical-stage oncology company, announces a presentation of clinical research involving its large surface area microparticle (LSAM) investigational drugs at DDW 2023 in May and publication at ASCO Annual Meeting in June.The DDW poster entitled “Intracystic Injecti...

Related Keywords

China ,South Korea ,Japan ,Canada ,Australia ,Dan Eramian ,Holly Maulhardt ,Somashekar Krishna ,Shelagh Verco ,Opus Biotech Communications ,Ohio State University Wexner Medical Center ,Large Surface Area Microparticle Paclitaxel ,Intraductal Papillary Mucinous Neoplasms ,Expanded Access Protocol ,Ohio State University Wexner Medical ,Endosc Int Open ,Private Securities Litigation Reform Act ,